TET2 and hepatocellular carcinoma: Theoretically, gut microbiota could regulate the TET2 level in B cells by modulating oxidative stress [107], and TET2 downregulation supported antitumor immunity to improve anti-programmed death (PD)-1 treatment for HCC [105].